-
More Device Approvals, Higher Risks in Europe than U.S.
29 June 2016. An analysis of regulatory approvals and outcomes shows medical devices are reviewed and approved faster in Europe than the U.S., but also face more safety issues later on. A team from Kings College London and Harvard University published its findings yesterday in the journal BMJ. Researchers led by Aaron Kesselheim, a bioethicist…
-
Animal-Free Leather Company Gains $40M in Venture Funds
A company making leather for consumer goods with tissue engineering and gene-editing from living cells is raising $40 million in its second venture round.
-
3-D Printing Technique Devised for Replacement Cartilage
Biomedical engineers developed a process for directly printing replacement cartilage without the scaffolds needed in previous tissue engineering techniques.
-
Partnership Advising Women on C-Section Options
An academic-business initiative is providing pregnant women with more information on birth options, particularly Cesarean section surgery.
-
Grant for Research on Drugs to Improve Tissue Transplants
27 June 2016. Department of Defense is funding research on new drugs that aim to improve the quality of tissue and limbs for transplants donated from people whose brains stop working. DoD awarded the grant of nearly $1 million to the Institute for Transformative Molecular Medicine at Case Western Reserve University School of Medicine in…
-
Genome Editing Company Adds $38M in Venture Funds
Crispr Therapeutics, a company creating treatments for disease that edit the human genome, is raising another $38 million in its second venture financing round.
-
Start-Up Developing Nanomedicines for Transplants
A spin-off enterprise from Medical University of South Carolina is creating drug delivery techniques that make it safer for patients needing organ transplants.
-
App Evaluates Chest Pain Patients for Discharge
A new iPhone app helps emergency physicians decide whether a patient with chest pain can be safely discharged from a hospital or needs further tests.
-
Celgene, Medical Centers to Partner on Cancer Therapies
Biopharmaceutical company Celgene Corp. and a consortium of four medical research institutes are collaborating on new diagnostics and treatments for cancer.
-
Immunotherapy Company Raises $70 Million in IPO
Selecta Biosciences, a biotechnology company developing treatments harnessing the immune system, is raising $70 million in its initial public offering.